Brain-penetrant CAMKK2 inhibitor

N/A

Report date: 2025/03/19 11:43:20
NME

Base Information

Drug NameBrain-penetrant CAMKK2 inhibitor
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionCalcium/calmodulin-dependent protein kinase kinase 2 inhibitors
TargetsCalcium/calmodulin-dependent protein kinase kinase 2
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A